These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17944168)

  • 1. Recently approved systemic therapies for acne vulgaris and rosacea.
    Del Rosso JQ
    Cutis; 2007 Aug; 80(2):113-20. PubMed ID: 17944168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflamatory dose doxycycline in the treatment of rosacea.
    Del Rosso JQ
    J Drugs Dermatol; 2009 Jul; 8(7):664-8. PubMed ID: 19588643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.
    Jackson JM; Kircik LH; Lorenz DJ
    J Drugs Dermatol; 2013 Mar; 12(3):292-8. PubMed ID: 23545911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline 40 mg capsules (30 mg immediate-release/10 mg delayed-release beads): anti-inflammatory dose in rosacea.
    McKeage K; Deeks ED
    Am J Clin Dermatol; 2010; 11(3):217-22. PubMed ID: 20369903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acne vulgaris. A comparison of doxycycline versus minocycline].
    Laux B
    Hautarzt; 1989 Sep; 40(9):577-81. PubMed ID: 2530191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subantimicrobial dose doxycycline for acne and rosacea.
    Bikowski JB
    Skinmed; 2003; 2(4):234-45. PubMed ID: 14673277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antibiotic therapies for acne and rosacea.
    Mays RM; Gordon RA; Wilson JM; Silapunt S
    Dermatol Ther; 2012; 25(1):23-37. PubMed ID: 22591497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB; Dinehart S; Stough D; Plott RT; ;
    Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
    Fowler JF
    J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial.
    Niren NM; Torok HM
    Cutis; 2006 Jan; 77(1 Suppl):17-28. PubMed ID: 16871775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.
    Toossi P; Farshchian M; Malekzad F; Mohtasham N; Kimyai-Asadi A
    J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of papulopustular rosacea: rationale for combination therapy.
    Bhatia ND; Del Rosso JQ
    J Drugs Dermatol; 2012 Jul; 11(7):838-44. PubMed ID: 22777226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads).
    Webster GF
    Cutis; 2010 Nov; 86(5 Suppl):7-15. PubMed ID: 21229826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
    Leyden JJ; Bruce S; Lee CS; Ling M; Sheth PB; Stewart DM; Werschler WP; Gilbert RD; Kircik L
    J Drugs Dermatol; 2013 Jun; 12(6):658-63. PubMed ID: 23839182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.
    Del Rosso JQ; Webster GF; Jackson M; Rendon M; Rich P; Torok H; Bradshaw M
    J Am Acad Dermatol; 2007 May; 56(5):791-802. PubMed ID: 17367893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline in the treatment of acne: latest findings.
    Maffeis L; Veraldi S
    G Ital Dermatol Venereol; 2010 Jun; 145(3):425-9. PubMed ID: 20461050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.
    Del Rosso JQ; Thiboutot D; Gallo R; Webster G; Tanghetti E; Eichenfield LF; Stein-Gold L; Berson D; Zaenglein A
    Cutis; 2014 Jan; 93(1):18-28. PubMed ID: 24505581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.